(Q35989402)

11 August 2017

1 reference

title

Oxaliplatin: in operable colorectal cancer (English)

1 reference

11 August 2017

1 reference

1 reference

3

David P Figgitt

1 reference

11 August 2017

Susan J Keam

1

1 reference

11 August 2017

Christopher J Dunn

series ordinal

2

1 reference

11 August 2017

publication date

1 January 2005

1 reference

11 August 2017

1 reference

11 August 2017

volume

65

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

89-96; discussion 97-8

1 reference

Lack of pharmacokinetic interaction between 5-fluorouracil and oxaliplatin

11 August 2017

cites work

1 reference

12 December 2020

Search for the optimal schedule for the oxaliplatin/5-fluorouracil association modulated or not by folinic acid: preclinical data.

1 reference

12 December 2020

Multi-modality approach in curative local treatment of early rectal carcinomas

1 reference

12 December 2020

The evolving role of oxaliplatin in the management of colorectal cancer.

1 reference

12 December 2020

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

12 December 2020

Oxaliplatin: a review of its use in the management of metastatic colorectal cancer

1 reference

12 December 2020

Adjuvant therapy of resectable rectal cancer

1 reference

12 December 2020

Cellular and molecular pharmacology of oxaliplatin.

1 reference

12 December 2020

Adjuvant therapy in colon cancer: current status and future directions

1 reference

12 December 2020

Influence of oxaliplatin on 5-fluorouracil plasma clearance and clinical consequences

1 reference

12 December 2020

Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies

1 reference

12 December 2020

Oxaliplatin: a review of its use in combination therapy for advanced metastatic colorectal cancer

1 reference

12 December 2020

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer

1 reference

12 December 2020

A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer.

1 reference

12 December 2020

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

1 reference

12 December 2020

Understanding surgeon performance and improving patient outcomes

1 reference

12 December 2020

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

1 reference

12 December 2020

Future directions in adjuvant therapy for stage III colon carcinoma.

1 reference

12 December 2020

Radiochemotherapy in rectal cancer: the role of oxaliplatin

1 reference

12 December 2020

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

12 December 2020

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

12 December 2020

10.2165/00003495-200565010-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

1037256780

0 references

1 reference